ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CRVO vs CELU // RSI-14 & 200D SMA MOMENTUM

CervoMed Inc. (NASDAQ) VS. Celularity Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: CRVO 1 — CELU 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CELU
rsi-technicals
24.1
rsi-technicals
35.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRVO VS. CELU) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CRVO CELU SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 24.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -58.90% -51.00% -7.90 CELU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 CRVO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 24.1 35.9 -11.86 CELU /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $26.5M $27.6M -$1.1M CELU /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CRVO REV CELU REV CRVO GROSS % CELU GROSS % CRVO FCF CELU FCF
FY 2025 $4.0M $26.6M — 24.4% -$23.4M -$13.3M
FY 2024 $9.7M $54.2M — 72.4% -$16.5M -$6.6M
FY 2023 $7.1M $22.8M — — -$7.4M -$38.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRVO // BETA —
CELU // BETA —